Citius Pharmaceuticals Inc (CTXR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 06-2025 | 03-2025 | 12-2024 | 09-2024 | 06-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -30,997 | -21,793 | -10,281 | -39,426 | -28,349 |
| Depreciation Amortization | 152 | 111 | 55 | 210 | 156 |
| Income taxes - deferred | 793 | 529 | 264 | 576 | 432 |
| Accounts payable and accrued liabilities | 5,167 | 4,441 | 2,437 | 2,000 | -1,264 |
| Other Working Capital | 7,433 | 6,661 | 2,712 | -1,685 | -4,011 |
| Other Operating Activity | 2,780 | 786 | 88 | 10,124 | 10,747 |
| Operating Cash Flow | $-14,672 | $-9,265 | $-4,726 | $-28,201 | $-22,289 |
| Cash Flows From Investing Activities | |||||
| Other Investing Activity | 0 | 0 | 0 | -5,000 | 0 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $-5,000 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,300 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 16,509 | 6,040 | 2,574 | 13,804 | 13,719 |
| Other Financing Activity | -300 | 0 | 0 | -3,831 | 0 |
| Financing Cash Flow | $17,509 | $6,040 | $2,574 | $9,972 | $13,719 |
| Beginning Cash Position | 3,252 | 3,252 | 3,252 | 26,481 | 26,481 |
| End Cash Position | 6,089 | 26 | 1,100 | 3,252 | 17,911 |
| Net Cash Flow | $2,837 | $-3,226 | $-2,152 | $-23,229 | $-8,570 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,672 | -9,265 | -4,726 | -28,201 | -22,289 |
| Free Cash Flow | -14,672 | -9,265 | -4,726 | -28,201 | -22,289 |